-
Acorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development
Tuesday, January 19, 2016 - 10:40am | 322Read More...Acorda Therapeutics Inc (NASDAQ: ACOR), a biopharmaceutical company that develops therapies for neurological disorders, on Tuesday announced that it has acquired Biotie Therapies Oyj (ADR) (NASDAQ: BITI) for $25.60 per ADS. Biotie Therapies is a Finland-based drug development company...
-
Biotie Therapies Surging Following IPO Debut
Thursday, June 11, 2015 - 4:18pm | 221Read More...Shares of Biotie Therapies Corp. (NASDAQ: BITI) traded higher by more than 39 percent in their public debut. The Finland-based firm is a specialized drug development company focused on products for neurodegenerative and psychiatric disorders. The company is developing a therapy to extend the...
-
Biotie Therapies Making Strides In Neurodegenerative Diseases
Wednesday, June 10, 2015 - 12:50pm | 887Read More...Finnish Biotech company Biotie Therapies (NASDAQ: BITI) (OTC: BIOZF) hopes to raise $56 million in its upcoming IPO this Friday, June 12. The company will offer 3.8 ADSs at price of $14.82, up 12 percent from its original offer. The deal was initially set for 3.4 million ADSs at the same price...
